Cite
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse Following Allogeneic Stem Cell Transplantation. Part II: Chronic Leukemias, Myeloproliferative Neoplasms, and Lymphoid Malignancies
MLA
Kröger, Nicolaus, et al. “NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse Following Allogeneic Stem Cell Transplantation. Part II: Chronic Leukemias, Myeloproliferative Neoplasms, and Lymphoid Malignancies.” Biology of Blood & Marrow Transplantation, vol. 16, no. 10, Oct. 2010, pp. 1325–46. EBSCOhost, https://doi.org/10.1016/j.bbmt.2010.07.001.
APA
Kröger, N., Bacher, U., Bader, P., Böttcher, S., Borowitz, M. J., Dreger, P., Khouri, I., Olavarria, E., Radich, J., Stock, W., Vose, J. M., Weisdorf, D., Willasch, A., Giralt, S., Bishop, M. R., & Wayne, A. S. (2010). NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse Following Allogeneic Stem Cell Transplantation. Part II: Chronic Leukemias, Myeloproliferative Neoplasms, and Lymphoid Malignancies. Biology of Blood & Marrow Transplantation, 16(10), 1325–1346. https://doi.org/10.1016/j.bbmt.2010.07.001
Chicago
Kröger, Nicolaus, Ulrike Bacher, Peter Bader, Sebastian Böttcher, Michael J. Borowitz, Peter Dreger, Issa Khouri, et al. 2010. “NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse Following Allogeneic Stem Cell Transplantation. Part II: Chronic Leukemias, Myeloproliferative Neoplasms, and Lymphoid Malignancies.” Biology of Blood & Marrow Transplantation 16 (10): 1325–46. doi:10.1016/j.bbmt.2010.07.001.